Literature DB >> 2725375

Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia.

C Bower1, F J Stanley.   

Abstract

A population-based case-control study was conducted to test the hypothesis that the risk of the occurrence of neural-tube defects in infants with no other birth defects (isolated neural-tube defects) is associated inversely with the maternal dietary intake of free and/or total folate in early pregnancy. Information was collected from the mothers of 77 case subjects with isolated neural-tube defects who were born in Western Australia from 1982 to 1984, from the mothers of 77 control subjects with birth defects other than neural-tube defects (control group 1) and from the mothers of 154 control subjects with no birth defects (control group 2). The case and control subjects were matched individually by the date of the mother's last menstrual period. Odds ratios were adjusted for a number of potentially-confounding variables, such as the country of birth of the parents, paternal social class, previous pregnancy outcome, interval between index and previous pregnancy and pregnancy order. Crude and adjusted odds ratios showed a protective effect of an increasing intake of free folate in the first six weeks of pregnancy. Adjusted odds ratios, with reference to the lowest quartile of intake, (and their 95% confidence intervals) were 0.72 (0.25-2.08), 0.37 (0.11-1.23) and 0.31 (0.10-0.97) for quartiles 2-4 when control group 1 was used, and 0.44 (0.17-1.13), 0.34 (0.13-0.90) and 0.16 (0.06-0.49) when control group 2 was used. Similar, but weaker, trends were seen when total folate intake was the exposure variable. These findings support the hypothesis that the dietary intake of folate in early pregnancy protects against the occurrence of isolated neural-tube defects in infants. Measures of postpartum dietary folate and of postpartum serum and red-cell folate levels showed no association with the occurrence of neural-tube defects in infants.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725375     DOI: 10.5694/j.1326-5377.1989.tb136723.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  36 in total

Review 1.  Folic acid in the prevention of neural tube defects.

Authors:  J M Scott; P N Kirke; D G Weir
Journal:  Ir J Med Sci       Date:  1992-10       Impact factor: 1.568

2.  Understanding nutritional epidemiology and its role in policy.

Authors:  Ambika Satija; Edward Yu; Walter C Willett; Frank B Hu
Journal:  Adv Nutr       Date:  2015-01-15       Impact factor: 8.701

3.  Periconceptional vitamin supplementation and neural tube defects; evidence from a case-control study in Western Australia and a review of recent publications.

Authors:  C Bower; F J Stanley
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

4.  Congenital Malformations and Consequential Epidemiology.

Authors:  Martha M Werler
Journal:  Curr Epidemiol Rep       Date:  2015-03

Review 5.  Fetal drug therapy.

Authors:  M I Evans; P G Pryde; A Reichler; M Bardicef; M P Johnson
Journal:  West J Med       Date:  1993-09

Review 6.  The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects.

Authors:  Anne M Molloy; Lawrence C Brody; James L Mills; John M Scott; Peadar N Kirke
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-04

Review 7.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 8.  Folic acid to reduce neonatal mortality from neural tube disorders.

Authors:  Hannah Blencowe; Simon Cousens; Bernadette Modell; Joy Lawn
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

9.  The Human Genome Project and eugenic concerns.

Authors:  K L Garver; B Garver
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

10.  Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists.

Authors:  M I Van Allen; F C Fraser; L Dallaire; J Allanson; D R McLeod; E Andermann; J M Friedman
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.